Cardiometabolic‐Inflammatory Risk Factors and Cognitive Decline Among Older Indians—Report From a Nationally Representative, Longitudinal Study
Open Access
- 15 December 2025
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 800-806
Abstract
Background: Rapid increase in cardiometabolic diseases in India may contribute to increased incidence of late‐life cognitive impairment. This study focuses on associations between baseline cardiometabolic risk factors and subsequent decline in cognitive function among older adults in India, leveraging data from two waves (Wave 1: 2017–2020, Wave 2: 2022–2024) of the Longitudinal Aging Study in India–Diagnostic Assessment of Dementia (LASI‐DAD). Methods: Analysis included longitudinal data of 1554 study participants. A summary measure of different cognitive functional domains was used. Cognitive decline was defined as annual decline in cognitive score ≥ 0.05 times the standard deviation of the summary score. Cardiometabolic risk was characterized using cardiovascular, metabolic, and inflammatory biomarkers. Multivariate, multinomial logistic regression analysis was used to examine the associations between cardiometabolic risk and cognitive decline. Results: At baseline, 71.7% of the sample had elevated homocysteine levels, 44.4% had elevated blood pressure, 23% had elevated glycosylated hemoglobin (HbA1c), and 6.7% had elevated uric acid levels. Between the two waves, 34.8% experienced significant cognitive decline, while 35.6% died. Multivariate multinomial logistic regression showed significant cognitive decline was associated with elevated blood pressure [odds ratio (OR): 1.7, 95% confidence interval (CI) 1.3–2.2], elevated HbA1c (OR: 1.1, 95% CI: 1.0–1.2), being overweight (OR: 1.4, 95% CI: 1.0–2.0), and elevated uric acid level (OR: 1.2, 95% CI: 1.0–1.3). Those with hypertension had 1.5 times higher odds of mortality (95% confidence interval: 1.2–2.0), while those with diabetes mellitus or elevated pro‐brain natriuretic peptide had 1.2 times (95% CI: 1.1–1.4), and 1.8 times (95% CI: 1.1–1.4) higher odds of mortality. Conclusion: Cardiometabolic risk factors play a significant role in late‐life cognitive decline and death among older Indians. These longitudinal relationships from LASI‐DAD highlight potentially modifiable risk factors and inform potential prevention policies.Keywords
Funding Information
- National Institutes of Health (R01 AG051125)
This publication has 29 references indexed in Scilit:
- High-sensitivity cardiac troponin T and N-terminal b-type natriuretic propeptide are associated with cardiac and all-cause mortality in older adults – A population-based ten-year follow-up studyClinica Chimica Acta, 2024
- The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigationAgeing Research Reviews, 2023
- Association between C-reactive protein, neutrophils, lymphocytes, cognition, and functional capacity in an oldest old populationBiomarkers in Neuropsychiatry, 2023
- Prevalence of dementia in India: National and state estimates from a nationwide studyAlzheimer's & Dementia, 2023
- Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) study and Tata Longitudinal Study on Aging (TLSA): Study protocolsAlzheimer's & Dementia, 2020
- Metabolic syndrome: The Indian public health perspectiveMedical Journal Armed Forces India, 2020
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Cardiovascular Diseases in India Compared With the United StatesJACC, 2018
- The Raven's Progressive Matrices: Change and Stability over Culture and TimeCognitive Psychology, 2000
- A hindi version of the MMSE: The development of a cognitive screening instrument for a largely illiterate rural elderly population in indiaInternational Journal of Geriatric Psychiatry, 1995